Delivery Order W911SR22D0009-W911SR23F0057
Award Date
3/7/23
Potential Completion Date
1/5/28
Potential Value
$9.1M
Funding Federal Agency
Joint PEO Chemical and Biological Defense
Contracting Federal Agency
ACC Aberdeen Proving Ground
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Available for Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Alachua, FL 32615, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Walsh Healy Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Resilience Government Services, Inc. (doing business as Nanotherapeutics Inc.), a technology-focused biomanufacturing company, for a Clinical Development Phase 2 Study. The contract is valued at $107,935,344.00 and has an ultimate completion date of February 29, 2028. The contract was awarded on January 4, 2022 by the Joint Program Executive Office for Chemical and Biological Defense, a component of the U.S. Department of the Army. No set-aside designation was...
This is a definitive contract awarded by the Department of the Army's Joint PEO Chemical and Biological Defense, a defense agency, to Resilience Government Services, Inc. (doing business as Nanotherapeutics Inc.). The $366,290,602.35 cost-plus-fixed-fee contract is for the Medical Countermeasures Advanced Development and Manufacturing (MCM ADM) Capability, with a period of performance through October 31, 2023. As a prime contractor, Resilience has provided a range of goods and services related...
This federal contract award, W911SR22D0009|W911SR22F0073, was issued by the Joint Program Executive Office for Chemical and Biological Defense, a Defense agency, to Resilience Government Services, Inc., doing business as Nanotherapeutics Inc. The $4,861,155.86 contract is a Delivery Order under a Cost Plus Fixed Fee contract type, with a period of performance ending on February 28, 2025. The contract supports DS Process Characterization, which likely refers to characterization and development of...
The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a $5,107,357.36 Other Transaction Agreement to Resilience Government Services, Inc., doing business as Nanotherapeutics Inc., a technology-focused biomanufacturing company. The contract, which has no set-aside designation, is for the development of a "Plasmid Platform Protype" and is part of a larger $5.7 million Indefinite Delivery Vehicle aimed at transferring capabilities to...
This is a definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services (HHS), to Resilience Government Services, Inc., doing business as Nanotherapeutics Inc. The $29,026,970.00 cost-plus-fixed-fee contract was awarded on September 9, 2019 to perform work under HHS-NIH-NIAID-BAA2018. The contract has an ultimate completion date of August 17, 2024 and does not have a set-aside designation....
This is a $3,044,549.00 fixed-price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Resilience Government Services, Inc. (doing business as Nanotherapeutics Inc.). The contract is for biomedical research and development work, with a period of performance ending on March 31, 2010. No set-aside designations were used. Resilience Government Services, a technology-focused biomanufacturing company, has...
This is a delivery order award under the Preclinical Services for Biopharmaceutical Product Development Indefinite Delivery Indefinite Quantity (IDIQ) contract, issued by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID). The $816,039.00 award to Resilience Government Services, Inc. (doing business as Nanotherapeutics Inc.) is for stability testing of NTM-1632 and NTM-1633. This award does not...
This is a $31,006,981.93 cost-plus-fixed-fee definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Resilience Government Services, Inc. (doing business as Nanotherapeutics Inc.) for the development of an inhaled dry-powder formulation of the antiviral drug cidofovir. The contract is for the postexposure prophylaxis and treatment of smallpox and was not set aside for any special business designation. Resilience has previously performed other chemical,...
This federal contract award, valued at $330,136,246.14, was granted by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency within the U.S. Department of Health and Human Services, to 4J Therapeutics Inc., a self-certified small disadvantaged business. The contract's objective is to demonstrate the versatility and efficacy of 4J Therapeutics' programmable antiviral technology platform by assembling a preclinical package for LNA14, performing a Phase 1a...
This is a $16,413,163.00 Cost Plus Fixed Fee contract awarded by the U.S. Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response (ASPR) to Mapp Biopharmaceutical, Inc., a biotechnology company specializing in antibody-based therapeutics and medical countermeasures against infectious diseases and biothreats. The contract is for the development of a pan-botulinum neurotoxin medical countermeasure, with a period of performance ending on June 30,...